导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -1.26% | 2669/4773 |
| 近一周 | 0.90% | 807/5467 |
| 近一月 | -4.96% | 2052/5421 |
| 近一季 | -11.97% | 3634/5238 |
| 近半年 | -5.65% | 3161/4931 |
| 近一年 | -6.51% | 3191/4400 |
| 近两年 | 116.30% | 450/2954 |
| 近三年 | 70.63% | 327/2253 |
| 成立以来 | 80.49% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.18% 1610/4961 |
11.90% 2271/5312 |
- - |
- - |
| 2025 | 42.09% 709/4813 |
8.70% 435/3635 |
- 2782/4076 |
43.53% 650/4524 |
-8.93% 3975/4813 |
| 2024 | 24.10% 306/3463 |
-7.79% 2191/2808 |
-1.01% 893/3014 |
14.45% 1969/3129 |
18.80% 62/3463 |
| 2023 | -3.85% 654/2656 |
9.88% 391/2280 |
0.14% 338/2385 |
-10.35% 1986/2515 |
-2.53% 488/2655 |
| 2022 | -28.87% 1582/2207 |
-24.69% 1775/1919 |
4.87% 966/2016 |
-16.21% 1424/2113 |
7.49% 304/2208 |
| 2021 | -2.11% 835/1822 |
-9.17% 1103/1255 |
16.06% 212/1330 |
-10.21% 1216/1466 |
3.42% 436/1822 |
| 2020 | 42.00% 278/1250 |
4.06% 91/1028 |
25.48% 153/1067 |
4.47% 953/1164 |
4.09% 870/1184 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 港股医疗ETF | 1.4546 | 31.90% |
| 华富中证港股通创新药指数型发起式A | 1.1637 | 30.96% |
| 天弘恒生沪深港创新药精选50ETF发起联接A | 1.3128 | 30.52% |
| 中欧中证港股通创新药指数发起A | 1.6103 | 30.52% |
| 嘉实中证港股通创新药指数发起式C | 0.8566 | 30.50% |
| 中欧中证港股通创新药指数发起C | 1.4583 | 30.44% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8927 | 30.26% |
| 景顺长城中证港股通创新药ETF联接C | 1.4696 | 29.97% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8736 | 29.94% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8719 | 29.88% |
| 安信深圳科技指数(LOF)A VS. 长安沪深300非周期A(740101) |